|
|
|
 |
| March 13, 2007 |
First Coast
News, "Vioxx Jury Awards $47.5M to Idaho
Couple" |
Merck & Co.'s
painkiller Vioxx contributed to an Idaho postal worker's
heart attack, a jury in Atlantic City ruled Monday, reversing
the verdict in the man's first trial and hitting Merck
with a total of $47.5 million in damages. In one of Merck's
biggest losses over the drug so far, the jurors awarded
the man and his wife $20 million in compensatory damages
Monday morning, then later said Merck should pay $27.5
million in punitive damages.
The verdict in the case
of Frederick "Mike" Humeston, who was granted a second trial in light
of new evidence, means Merck has now won nine cases and lost five in the mushrooming
litigation over its former blockbuster arthritis pill. Humeston, 61, of Boise,
Idaho, suffered a heart attack in September 2001, several months before Merck
- under pressure from federal regulators - put a stronger warning about the cardiovascular
risks of Vioxx on the drug's detailed package insert.
The five-man, three-woman
jury ruled on March 2 that Merck was negligent and did not provide adequate warning
about those risks before Humeston's heart attack. The jurors, after deliberating
for about five hours over two days, awarded Humeston $18 million in compensatory
damages for pain and suffering and gave $2 million to his wife, Mary. Then, after
brief arguments over punitive damages, the jury deliberated briefly late Monday
afternoon and decided to assess $27.5 million in punitive damages against Merck. "This
is why you keep fighting," said Humeston's lawyer. "A little guy from
Idaho took on Merck and beat them big time." |
|
| Lieff
Cabraser: Experienced Vioxx Injury Lawyers |
| Founded
in 1972, Lieff Cabraser Heimann & Bernstein,
LLP is an over-fifty attorney law firm with
offices in San Francisco, New York and Nashville.
In each of the last five years, the National
Law Journal has recognized
Lieff Cabraser as one of the top plaintiffs law
firms in America. |
| For
our personal injury Vioxx cases, we bring a
team of experienced lawyers. In addition,
we have on staff multiple nurses, legal assistants,
scientific analysts and case clerks to assist
our Vioxx attorneys. Learn more about advantages
we offer patients with Vioxx problems and
injuries. |
|
|
|
We
have a nationwide team of experienced
injury Vioxx lawyers assigned to Vioxx
trials. |
|
We
provide individual attentive service. Learn
more about our firm. |
|
We
have retained the leading national
medical experts on Vioxx and have
a staff of nurses to assist the
prosecution of the claims of our
clients. |
|
|
|
| We
have been contacted by thousands of Vioxx drug patients
nationwide as part of the Vioxx litigation. We have represented
patients who ingested prescription drugs with dangerous,
undisclosed side effects in personal injury lawsuits
across America, including residents of Alaska, Alabama,
Arkansas, Arizona, California, Colorado, Connecticut,
Delaware, Florida, Georgia, Hawaii, Idaho, Illinois,
Indiana, Kansas, Kentucky, Louisiana, Massachusetts,
Maryland, Maine, Michigan, Minnesota, Missouri, Montana,
North Carolina, North Dakota, Nebraska, New Hampshire,
New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma,
Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee,
Texas, Utah, Virginia, Vermont, Washington, Wisconsin,
West Virginia and Wyoming. |
| Persons
living outside the United States who have been injured
by an American product manufactured may also in certain
cases file Vioxx lawsuits for compensation for heart
attacks and strokes in United States courts. |
|
|
|
|
|
Lieff
Cabraser Heimann & Bernstein, LLP |
|
|
|
|
|
|
| Trademark
Notice |
| "Vioxx"
is a registered trademark of Merck. Lieff Cabraser Heimann
& Bernstein, LLP is in no way affiliated with Merck,
and the Vioxx trademark is used solely for informational
purposes. |
|
|
|
|
Copyright © 2008 Lieff Cabraser Heimann & Bernstein, LLP |
|
|
|
|
Vioxx
Recall: The international prescription
drug company Merck announced in September
2004 the worldwide withdrawal of the arthritis
medication Rofecoxib, sold in most countries
under the brand name Vioxx, because a study
showed an increased risk of heart attack
and stroke.
Vioxx
Trial: Patients who have suffered
injuries due to Vioxx have filed litigation
against Merck for selling Vioxx even though
Merck allegedly was aware of Vioxx's dangerous
side effects. |
|
|
|
|